Prevalence of EED and quality of life evaluated by Gastroesophageal Reflux Disease (GERD)-Q in Korean GERD patients - Preedom

Study identifier:NIS-GKR-DUM-2008/1

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

Prevalence of EED and quality of life evaluated by Gastroesophageal Reflux Disease (GERD)-Q in Korean GERD patients

Medical condition

Gastroesophageal Reflux Disease

Phase

-

Healthy volunteers

No

Study drug

-

Sex

All

Actual Enrollment

2000

Study type

Observational

Age

20 Years - 80 Years

Date

Study Start Date: 01 Sept 2008
Primary Completion Date: -
Study Completion Date: 01 Feb 2009

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals

Sponsors

AstraZeneca Pharmaceuticals

Collaborators

-

Inclusion and exclusion criteria